» Articles » PMID: 16554471

Cocaine Increases Dopamine Release by Mobilization of a Synapsin-dependent Reserve Pool

Overview
Journal J Neurosci
Specialty Neurology
Date 2006 Mar 24
PMID 16554471
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

Cocaine primarily exerts its behavioral effects by enhancing dopaminergic neurotransmission, amplifying dopamine-encoded sensorimotor integration. The presumed mechanism for this effect is inhibition of the dopamine transporter, which blocks dopamine uptake and prolongs the duration of dopamine in the extracellular space. However, there is growing evidence that cocaine can also augment dopamine release. Here, we directly monitored the actions of cocaine on dopamine release by using electrochemical detection to measure extracellular dopamine in the striatum of anesthetized mice. Cocaine enhanced the levels of striatal dopamine produced by electrical stimulation of dopaminergic neurons. Even after pretreatment with alpha-methyl-p-tyrosine, which depletes the readily releasable pool of dopamine, cocaine was still capable of elevating dopamine levels. This suggests that cocaine enhances dopamine release by mobilizing a reserve pool of dopamine-containing synaptic vesicles. To test this hypothesis, we examined electrically evoked dopamine release in synapsin I/II/III triple knock-out mice, which have impaired synaptic vesicle reserve pools. Knock-out of synapsins greatly reduced the ability of cocaine to enhance dopamine release with long stimulus trains or after depletion of the newly synthesized pool. We therefore conclude that cocaine enhances dopamine release and does so by mobilizing a synapsin-dependent reserve pool of dopamine-containing synaptic vesicles. This capacity to enhance exocytotic release of dopamine may be important for the psychostimulant actions of cocaine.

Citing Articles

Evidence of COMT dysfunction in the olfactory bulb in Parkinson's disease.

Beauchamp L, Ellett L, Juan S, Liu X, Hunt C, Parish C Acta Neuropathol. 2025; 149(1):21.

PMID: 40024917 PMC: 11872990. DOI: 10.1007/s00401-025-02861-y.


The WAVE complex in developmental and adulthood brain disorders.

Kim H, Berdasco C, Nairn A, Kim Y Exp Mol Med. 2025; 57(1):13-29.

PMID: 39774290 PMC: 11799376. DOI: 10.1038/s12276-024-01386-w.


The nucleus accumbens in reward and aversion processing: insights and implications.

Xu Y, Lin Y, Yu M, Zhou K Front Behav Neurosci. 2024; 18:1420028.

PMID: 39184934 PMC: 11341389. DOI: 10.3389/fnbeh.2024.1420028.


Fiber-based Probes for Electrophysiology, Photometry, Optical and Electrical Stimulation, Drug Delivery, and Fast-Scan Cyclic Voltammetry In Vivo.

Driscoll N, Antonini M, Cannon T, Maretich P, Olaitan G, Phi Van V bioRxiv. 2024; .

PMID: 38895451 PMC: 11185794. DOI: 10.1101/2024.06.07.598004.


Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's.

Brimblecombe K, Connor-Robson N, Bataille C, Roberts B, Gracie C, OConnor B Eur J Neurosci. 2023; 59(6):1242-1259.

PMID: 37941514 PMC: 11426196. DOI: 10.1111/ejn.16180.


References
1.
Bauman P, Maitre L . Is drug inhibition of dopamine uptake a misinterpretation of in vitro experiments?. Nature. 1976; 264(5588):789-90. DOI: 10.1038/264789a0. View

2.
Hilfiker S, Pieribone V, Czernik A, Kao H, Augustine G, Greengard P . Synapsins as regulators of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci. 1999; 354(1381):269-79. PMC: 1692497. DOI: 10.1098/rstb.1999.0378. View

3.
Robinson T, Kolb B . Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci. 1999; 11(5):1598-604. DOI: 10.1046/j.1460-9568.1999.00576.x. View

4.
Premkumar L . Selective potentiation of L-type calcium channel currents by cocaine in cardiac myocytes. Mol Pharmacol. 1999; 56(6):1138-42. DOI: 10.1124/mol.56.6.1138. View

5.
Shore P . Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron. J Pharm Pharmacol. 1976; 28(11):855-7. DOI: 10.1111/j.2042-7158.1976.tb04078.x. View